Imaging Technology

MAY 31, 2023

We can’t treat what we don’t see, which is why we require precise image quality to help diagnose, plan treatment for, and monitor disease,” explains Prof. Medical imaging is a crucial tool for diagnosing disease, identifying a course of treatment, and determining whether therapy is successful for millions of patients around the world.

Nuclear Medicine 86

Nuclear Medicine Healthcare Healthcare IT 86

AuntMinnie

MARCH 26, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. This theranostic therapy first demonstrated how using diagnostic imaging with a radioactive probe, gallium-68 (Ga-68 dotatate injection), could locate NETs on PET scans.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

Imaging Technology

MAY 30, 2023

This event marks a major milestone in the expansion of Blue Earth Diagnostics’ robust prostate cancer portfolio. It is labeled with the radioisotope fluorine-18 (18F) to enable PET imaging of the prostate and other areas of the body where prostate cancer may have spread. Gauden , D.Phil., The adverse reactions reported in ≥0.4%

Diagnostic 77

Diagnostic Imaging Radiopharmaceuticals Diagnostic Imaging 77

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. This theranostic therapy first demonstrated how using diagnostic imaging with a radioactive probe, gallium-68 (Ga-68 dotatate injection), could locate NETs on PET scans.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

AuntMinnie

JULY 8, 2024

Three grade 3 CAM-H2 treatment emergent adverse events (TEAE) were reported in three patients who had a previous history of thrombocytopenia, lung disease, or liver disease, with no grade 4 or 5 adverse events reported. Twenty of the 26 scans from patients with active tumors were NeoB-positive, six NeoB-negative.

Disease 105

Disease Nuclear Medicine Imaging Bone Scan 105

Imaging Technology

MAY 2, 2023

For example, results showed that among the subgroup (n=76) of patients in the Evaluable PET Scan Population who had undergone primary treatment with radiation therapy for prostate cancer, the overall patient-level DR was 99% (75/76) and consistently high across the three independent readers (range 93-99%).

Diagnostic 93

Diagnostic Radiopharmaceuticals Imaging Radiation 93